Amgen (AMGN) Announces Kyprolis MAA Acceptance by EMA
Tweet Send to a Friend
Amgen (Nasdaq: AMGN) and its subsidiary Onyx Pharmaceuticals, Inc. announced that the European Medicines Agency (EMA) has accepted the Marketing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE